Nucleus Network | Nucleus Network - Melbourne, Australia
Status and phase
Conditions
Treatments
About
A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3003
Full description
A Phase 1, Randomized, Open-Label, Exploratory, Sequential, Pharmacokinetic Single Ascending Dose Study of IVL3003 Versus Multiple Doses of Aricept (Donepezil) Tablets in Healthy Subjects
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
42 participants in 4 patient groups
Loading...
Central trial contact
SungJin Eum
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal